Results 171 to 180 of about 198,762 (311)

Enhancing cancer vaccine efficacy via electrostatic engineering of an FcγR-targeted protein. [PDF]

Front Immunol
Wu CC, Chen CL, Chiang CY, Tu LL, Liu SJ, Leng CH, Chen HW.   +6 more
europepmc   +1 more source

Human cancer vaccines

Advanced Drug Delivery Reviews, 2006
Man, Stephen, Tabi, Zsuzsanna
openaire   +2 more sources

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Immunoinformatic insights for design and clinical prospects of pan-RAS cancer vaccine. [PDF]

Front Med (Lausanne)
Srivastava R, Rana TRK.
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Mapping the cancer vaccine landscape. [PDF]

J Immunother Cancer
Hu F, Li H, Lv W, Li M, Gale RP, Huang X, Liang Y.   +6 more
europepmc   +1 more source

History of cervical cancer and the role of the human papillomavirus, 1960–2000

, 2009
The history, largely untold, of the development of cervical cytology, of effective screening and its ultimate success in reducing cervical cancer incidence and mortality, and the viral cause of cervical cancer, took place within a complex social ...

core  

Cancer Vaccine Targeting Mutated GNAQ-Expressing Uveal Melanoma. [PDF]

Cancers (Basel)
Alexeev V, Terai M, Koshkin S, Igoucheva O, Sato T.   +4 more
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Converting focused ultrasound-based boiling histotripsy into a systemic cancer vaccine using antigen-capturing microparticles. [PDF]

Theranostics
Singh A, Chandrasekar SV, Chamani F, Ashar H, Hartson S, Fiering S, Ranjan A.   +6 more
europepmc   +1 more source